ALK — Alkaloid AD Skopje Income Statement
0.000.00%
- MKD36.07bn
- MKD38.65bn
- MKD19.01bn
- 66
- 33
- 52
- 47
Annual income statement for Alkaloid AD Skopje, fiscal year end - December 31st, MKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | MAS | MAS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 12,132 | 12,794 | 14,289 | 16,513 | 19,006 |
| Cost of Revenue | |||||
| Gross Profit | 5,434 | 5,765 | 6,454 | 7,575 | 8,612 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 10,786 | 11,315 | 12,619 | 14,690 | 17,014 |
| Operating Profit | 1,346 | 1,479 | 1,670 | 1,823 | 1,992 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 1,328 | 1,460 | 1,644 | 1,786 | 1,939 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,168 | 1,305 | 1,463 | 1,577 | 1,684 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 1,167 | 1,305 | 1,463 | 1,577 | 1,684 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1,167 | 1,305 | 1,463 | 1,577 | 1,684 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1,218 | 1,241 | 1,041 | 1,122 | 1,198 |
| Dividends per Share |